# Newly Diagnosed Systemic Lupus Erythematosus in a 14-Year-Old Female

## TL;DR

A 14-year-old girl is diagnosed with juvenile-onset systemic lupus erythematosus, highlighting the importance of early detection and treatment.

## Contribution

The case emphasizes the aggressive nature of juvenile-onset SLE and the need for early immunosuppressive therapy.

## Key findings

- The patient presented with persistent facial rash, headaches, and weight loss.
- The case underscores the importance of early recognition to prevent organ damage.
- Biologic therapies are increasingly being considered in managing juvenile-onset SLE.

## Abstract

Juvenile-onset systemic lupus erythematosus (jSLE) is a rare, life-threatening autoimmune disease that can be seen in the pediatric population. jSLE patients are more prone to highly aggressive forms of this condition when compared to adult-onset counterparts. This makes early recognition and adequate immunosuppressive therapies key in preventing end-organ damage. SLE is classically managed clinically with antimalarials and glucocorticoids, but injectable biologic therapies are slowly becoming part of mainstream care. Our case report highlights a 14-year-old female who presents with a persistent facial rash, headaches, and weight loss following treatment for Influenza B.